вторник, 3 марта 2015 г.

Actavis and Medicines360 announce FDA approval of LILETTA (levonorgestrel-releasing intrauterine system)

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, have announced the approval of LILETTA (levonorgestrel-releasing...



Комментариев нет:

Отправить комментарий